GSK chief Witty opens up to spinoff talk, with consumer health an obvious choice

Tracy Staton

GlaxoSmithKline CEO Andrew may be coming around on a breakup. At the J.P. Morgan Healthcare Conference, said he's open to the idea and pegged his joint venture with Novartis as a possible option.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS